Hayder Adnan Fawzi
Hayder Adnan Fawzi
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis | Euglenozoa Infections, Infections, Skin and Connective Tissue Diseases, cutaneous leishmaniasis, leishmaniasis, parasitic infectious disease, parasitic skin disorder, protozoa infectious disease, skin disorder, skin disorder caused by infection, vector-borne disease | Recruiting | Phase 2 | 2025-09-30 | NCT06797544 | |
| Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis | Euglenozoa Infections, Infections, Skin and Connective Tissue Diseases, cutaneous leishmaniasis, leishmaniasis, parasitic infectious disease, parasitic skin disorder, protozoa infectious disease, skin disorder, skin disorder caused by infection, vector-borne disease | Recruiting | Phase 2 | 2025-02-14 | NCT06798415 |